Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
COVID
Interventions
DRUG

Camostat Mesilate

400 mg tid, d1-d7

DRUG

Placebo

Instead of Camostat Mesilate, tid, d1-d7

DRUG

Hydroxychloroquine

400 mg bid on day 1, 200 mg bid d2-d7

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

Goethe University

OTHER

collaborator

St. Georg Hospital Leipzig, Germany

UNKNOWN

collaborator

Hospital Schwabing Munich, Germany

UNKNOWN

collaborator

Missioklinik, Wuerzburg, Germany

UNKNOWN

lead

Heinrich-Heine University, Duesseldorf

OTHER